HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yu Ma Selected Research

20-carboxyleukotriene B4

8/2016Anti-Inflammation Effects and Potential Mechanism of Saikosaponins by Regulating Nicotinate and Nicotinamide Metabolism and Arachidonic Acid Metabolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yu Ma Research Topics

Disease

57Neoplasms (Cancer)
07/2022 - 06/2005
20Tuberculosis (Tuberculoses)
10/2017 - 01/2002
15Inflammation (Inflammations)
07/2022 - 03/2014
11Neoplasm Metastasis (Metastasis)
01/2022 - 06/2005
11Infections
10/2021 - 01/2008
9Carcinoma (Carcinomatosis)
07/2022 - 06/2010
8Parkinson Disease (Parkinson's Disease)
05/2022 - 11/2012
8Hypertension (High Blood Pressure)
01/2019 - 06/2011
7Adenocarcinoma
06/2022 - 02/2002
7Asthma (Bronchial Asthma)
01/2022 - 02/2002
7Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 10/2007
6Epilepsy (Aura)
01/2019 - 01/2008
5Diabetic Foot
10/2022 - 10/2018
5Hepatocellular Carcinoma (Hepatoma)
03/2021 - 08/2011
5Diarrhea
02/2021 - 12/2019
5Colonic Neoplasms (Colon Cancer)
01/2021 - 12/2008
5Glioma (Gliomas)
01/2018 - 05/2008
4Wounds and Injuries (Trauma)
03/2022 - 05/2019
4Carcinogenesis
11/2021 - 11/2006
4Breast Neoplasms (Breast Cancer)
05/2021 - 05/2013
4Alzheimer Disease (Alzheimer's Disease)
03/2021 - 02/2014
4Endometrial Neoplasms (Endometrial Cancer)
01/2021 - 01/2013
4Necrosis
01/2020 - 06/2014
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2020 - 01/2010
4Optic Nerve Glioma
08/2017 - 01/2017
4Lung Neoplasms (Lung Cancer)
02/2012 - 02/2002
3COVID-19
10/2022 - 01/2022
3Hypoxia (Hypoxemia)
06/2022 - 10/2019
3Ulcer
05/2022 - 01/2020
3Poisoning
03/2022 - 10/2009
3Neuralgia (Stump Neuralgia)
02/2022 - 01/2009
3Pulmonary Hypertension
01/2022 - 02/2008
3Pathologic Processes
01/2022 - 11/2014
3Vascular Remodeling
01/2022 - 01/2014
3Pulmonary Arterial Hypertension
01/2022 - 01/2014
3Fibrosis (Cirrhosis)
01/2022 - 01/2014
3Lung Injury
01/2022 - 05/2019
3Type 2 Diabetes Mellitus (MODY)
02/2021 - 01/2019
3Pain (Aches)
01/2021 - 01/2009
3Myocardial Infarction
01/2021 - 08/2015
3Stomach Neoplasms (Stomach Cancer)
01/2021 - 12/2019
3Fistula
10/2020 - 01/2020
3Vascular System Injuries
01/2017 - 03/2016
3Seizures (Absence Seizure)
09/2013 - 06/2009

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
07/2022 - 11/2006
12Biological ProductsIBA
10/2022 - 12/2008
11Pharmaceutical PreparationsIBA
01/2022 - 07/2007
11Biomarkers (Surrogate Marker)IBA
01/2022 - 10/2007
8Glucose (Dextrose)FDA LinkGeneric
04/2022 - 01/2013
7CytokinesIBA
01/2022 - 04/2003
7RNA (Ribonucleic Acid)IBA
01/2021 - 08/2017
6chromium hexavalent ionIBA
07/2022 - 12/2019
6MicroRNAs (MicroRNA)IBA
01/2021 - 10/2016
6Long Noncoding RNAIBA
01/2021 - 10/2016
6AntigensIBA
01/2020 - 02/2002
6EnzymesIBA
01/2013 - 02/2002
5DNA (Deoxyribonucleic Acid)IBA
07/2022 - 11/2006
5Polysaccharides (Glycans)IBA
02/2021 - 12/2019
5VaccinesIBA
01/2021 - 04/2003
5PolymersIBA
12/2019 - 10/2009
5insulin-like growth factor binding protein-related protein 1IBA
08/2017 - 03/2007
4Therapeutic UsesIBA
12/2022 - 02/2004
4LipidsIBA
01/2022 - 09/2015
4Small Interfering RNA (siRNA)IBA
05/2021 - 06/2010
4Ion Channels (Ion Channel)IBA
01/2021 - 11/2018
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2019 - 04/2003
4Antineoplastic Agents (Antineoplastics)IBA
01/2019 - 02/2015
4Tuberculin (PPD)IBA
10/2017 - 08/2009
4Antitubercular AgentsIBA
01/2013 - 01/2008
3Glutamine (L-Glutamine)FDA Link
06/2022 - 02/2002
3CurcuminIBA
02/2022 - 06/2009
33' Untranslated Regions (3' UTR)IBA
02/2022 - 05/2003
3CollagenIBA
01/2022 - 10/2016
3ChemokinesIBA
01/2022 - 05/2017
3Competitive Endogenous RNAIBA
01/2022 - 01/2020
3Interleukin-6 (Interleukin 6)IBA
10/2021 - 09/2013
3Interleukin-1 (Interleukin 1)IBA
10/2021 - 04/2003
3Oxygen (Dioxygen)IBA
04/2021 - 01/2020
3Neuroprotective AgentsIBA
03/2021 - 12/2013
3Triglycerides (Triacylglycerol)IBA
01/2020 - 01/2013
3Adenosine Triphosphate (ATP)IBA
12/2019 - 01/2019
3Messenger RNA (mRNA)IBA
12/2019 - 11/2005
3Nitric Oxide (Nitrogen Monoxide)FDA Link
10/2019 - 04/2003
3ErbB Receptors (EGF Receptor)IBA
01/2019 - 01/2013
3Complement System Proteins (Complement)IBA
01/2018 - 01/2017
3InterferonsIBA
10/2017 - 06/2014
3Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2015 - 01/2012
3Insulin (Novolin)FDA Link
02/2015 - 01/2013
3salicylhydroxamic acid (SHAM)IBA
07/2014 - 01/2014
3Insulin-Like Growth Factor Binding ProteinsIBA
01/2013 - 12/2008
3Kainic Acid (Kainate)IBA
01/2011 - 01/2008

Therapy/Procedure

26Therapeutics
01/2022 - 06/2010
13Deep Brain Stimulation
05/2022 - 12/2006
12Drug Therapy (Chemotherapy)
02/2022 - 08/2009
6Transplantation
09/2020 - 08/2015
4Surgical Amputation (Amputations)
10/2022 - 01/2021
4Radiotherapy
01/2021 - 06/2014
4Aftercare (After-Treatment)
11/2018 - 11/2005
3Immunotherapy
01/2022 - 08/2009
3Neck Dissection (Radical Neck Dissection)
10/2020 - 01/2020